β-阿雷斯1 不同调节cAMP和ERK通路 下游的FSH受体
Sei Hyun Park1, Munkhzaya Byambaragchaa2, Ye Rin Yu3
1Graduate School of Animal BioScience, Hankyong National University, Anseong 17579, Republic of Korea.
Current issues in molecular biology
|January 30, 2026
概括
研究人员创造了功能性重组子淋巴激素 (LH和FSH),并发现β-arrestin1在调节FSH受体信号传递方面具有双重作用,对cAMP和ERK通路产生不同的影响.
科学领域:
- 生殖生物学 生殖生物学
- 分子内分泌学分子内分泌学
- 灵长类动物遗传学
背景情况:
- 淋巴激素,白质化激素 (LH) 和卵泡刺激激素 (FSH) 对于生殖功能至关重要.
- 了解灵长类性腺激素的结构和功能对于比较内分泌学和生殖研究至关重要.
研究的目的:
- 为了比较Cynomolgus和Rhesus子之间的淋巴激素基因序列 (LH和FSH子单元).
- 从这些灵长类动物中生产和表征复合单链LH和FSH蛋白质.
- 研究复合FSH的信号通路,包括β-arrestin的作用 1.
主要方法:
- 对LH和FSH亚单元基因的比较测序.
- 重组蛋白表达和N-糖化分析.
- 使用人类FSH受体表达细胞测量cAMP和ERK1/2激活的功能测试.
- 研究β-arrestin1在FSH受体信号传递中的作用.
主要成果:
- 同样的α和FSHβ子单元序列和Cynomolgus和Rhesus子之间的LHβ中微小的同义差异.
- 成功表达了N-糖基化复合子LH和FSH蛋白质.
- 重组子FSH激活了cAMP信号,并通过cAMP/PKA通路证明了特定物种的ERK激活时间.
- 贝塔-阿雷斯1表现出双重作用,负面调节cAMP信号,同时对ERK1/2激活至关重要.
结论:
- 建立了一个可靠的生产功能性重组灵长类性腺激素的系统.
- β-阿雷斯1差异调节FSH受体信号传递,影响cAMP和ERK通路.
- 在人类和老鼠受体之间观察到FSH受体信号定时的特定物种差异.
更多相关视频
相关概念视频
cAMP-dependent Protein Kinase Pathways
8.5K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
8.5K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Adrenergic Receptors: β Subtype
3.8K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
3.8K
Insulin: The Receptor and Signaling Pathways
3.1K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
3.1K
Antihypertensive Drugs: Action of β1 Blockers
2.0K
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
2.0K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.2K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.2K


